Back to search
Compensated Advanced Chronic Liver Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Compensated Advanced Chronic Liver Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Compensated Advanced Chronic Liver Disease trials you may qualify forThe primary objective of this study is to evaluate the role of spleen shear wave elastography (SWE-SSM) for ruling in and ruling out clinically significant port…
The goal of this randomised controlled trial is to evaluate the effect of carvedilol (a non-selective beta-blocker) in patients with compensated advanced chroni…
Zinc homeostasis could play a role in advanced chronic liver disease (cACLD) and its supplementation has been linked with improvement in liver function, decreas…
This multicenter, prospective, cohort study is designed to investigate how metabolic disorders (such as obesity, diabetes, and high cholesterol) influence the p…
Patients with chronic liver disease (CLD) are at risk of developing clinically significant portal hypertension (CSPH). In the Baveno VI consensus a new term "co…
Background: Advanced liver scarring leads to liver failure, liver cancer and premature death. It mainly affects people in the working age group (18-65 years) an…